» Authors » Jui-Hsiang Tang

Jui-Hsiang Tang

Explore the profile of Jui-Hsiang Tang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 43
Citations 338
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheng C, Tang J, Hsieh Y, Kuo Y, Fang K, Tseng C, et al.
Am J Gastroenterol . 2024 Oct; PMID: 39471473
Introduction: Postcolonoscopy colorectal cancers primarily occur in the right-sided colon because of missed adenomas and serrated polyps (SPs). Water exchange (WE) improves cleanliness and visibility of the right-sided colon. We...
2.
Hsu H, Tang J, Huang S, Huang C, Lin S, Huang S, et al.
Biomedicines . 2024 Mar; 12(3). PMID: 38540268
Background: The perioperative outcomes of a partial hepatectomy for hepatocellular carcinoma (HCC) have improved. However, high recurrence rates after a curative hepatectomy for HCC is still an issue. This study...
3.
Huang C, Lin S, Huang S, Yu M, Tang J, Tsai C, et al.
Cancers (Basel) . 2022 Nov; 14(21). PMID: 36358846
The outcomes of patients with hepatocellular carcinoma (HCC) are unsatisfactory because of its high recurrence rate. The Vessels that encapsulate tumor clusters (VETC) pattern is a unique vascular structure. In...
4.
Lo C, Yeh Y, Tang J, Chang C, Yeh H
Healthcare (Basel) . 2022 Aug; 10(8). PMID: 36011151
Colorectal cancer is the leading cause of cancer-associated morbidity and mortality worldwide. One of the causes of developing colorectal cancer is untreated colon adenomatous polyps. Clinically, polyps are detected in...
5.
Cheng C, Chen S, Su I, Wu C, Kuo Y, Chien T, et al.
Dig Dis Sci . 2022 Jul; 68(1):259-267. PMID: 35790704
Background: Current postpolypectomy guidelines treat 1-9 mm nonadvanced adenomas (NAAs) as carrying the same level of risk for metachronous advanced colorectal neoplasia (ACRN). Aims: To evaluate whether small (6-9 mm)...
6.
Wu Y, Hung Y, Chiu N, Lee R, Li C, Chao Y, et al.
Eur J Cancer . 2022 Mar; 166:208-218. PMID: 35306319
Introduction: Pancreatic ductal adenocarcinoma (PDAC) is highly aggressive and has poor prognosis. There are few biomarkers to inform treatment decisions, and collecting tumour samples for testing is challenging. Methods: Circulating...
7.
Yu C, Yeh H, Chang C, Tang J, Kao W, Chen W, et al.
Comput Methods Programs Biomed . 2021 Sep; 211:106382. PMID: 34555590
Background And Objective: Emergency physicians (EPs) frequently deal with abdominal pain, including that is caused by either gallstones or acute cholecystitis. Easy access and low cost justify point-of-care ultrasound (POCUS)...
8.
Chou T, Yeh H, Chang C, Tang J, Kao W, Su I, et al.
J Chin Med Assoc . 2021 Jul; 84(9):842-850. PMID: 34282076
Background: The prevalence of nonalcoholic fatty liver disease is increasing over time worldwide, with similar trends to those of diabetes and obesity. A liver biopsy, the gold standard of diagnosis,...
9.
Yu C, Chen Y, Chang S, Tang J, Wu J, Lin C
Eur J Gastroenterol Hepatol . 2021 Apr; 33(8):1117-1123. PMID: 33905216
Objective: End-stage liver disease is a global public health problem with a high mortality rate. Early identification of people at risk of poor prognosis is fundamental for decision-making in clinical...
10.
Kao W, Lin Y, Chang I, Chen C, Tang J, Chang C, et al.
J Chin Med Assoc . 2020 Dec; 84(3):261-266. PMID: 33306598
Background: Two recent studies in the adult and pediatric Nonalcoholic Steatohepatitis-Clinical Research Network (NASH-CRN) cohorts have shown that soluble interleukin-2 receptor alpha (IL2RA) levels increased with fibrosis severity. However, no...